Allergan Plc Executives
Allergan Plc employs about 17.4 K people. The company is managed by 35 executives with a total tenure of roughly 293 years, averaging almost 8.0 years of service per executive, having 497.14 employees per reported executive. Analysis of Allergan Plc's management performance can provide insight into the firm performance.
Brenton Saunders Chairman Chairman of the Board, President, Chief Executive Officer |
Paul Bisaro Chairman Executive Chairman |
Allergan |
Allergan Plc Management Team Effectiveness
The company has Return on Asset of (0.0564) % which means that on every $100 spent on assets, it lost $0.0564. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0913) %, meaning that it generated no profit with money invested by stockholders. Allergan Plc's management efficiency ratios could be used to measure how well Allergan Plc manages its routine affairs as well as how well it operates its assets and liabilities.Allergan Plc Workforce Comparison
Allergan Plc is number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—General industry is presently estimated at about 39,523. Allergan Plc totals roughly 17,400 in number of employees claiming about 44% of equities under Drug Manufacturers—General industry.
Allergan Plc Notable Stakeholders
An Allergan Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Allergan Plc often face trade-offs trying to please all of them. Allergan Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Allergan Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Brenton Saunders | Chairman of the Board, President, Chief Executive Officer | Profile | |
Paul Bisaro | Executive Chairman | Profile | |
Matthew Walsh | Chief Financial Officer, Executive Vice President | Profile | |
Robert Stewart | Executive VP and President of Generic and Global Operations | Profile | |
William Meury | Executive Vice President, Chief Commercial Officer | Profile | |
Wayne Swanton | Executive Vice President - Global Operations | Profile | |
Karen Ling | Chief Human Resource Officer, Executive Vice President | Profile | |
Philippe Schaison | Executive Vice President and President Allergan Medical | Profile | |
A Bailey | Executive Vice President, Chief Legal Officer and Corporate Secretary | Profile | |
CDavid Nicholson | Executive Vice President, Chief R&D Officer | Profile | |
Jonathon Kellerman | Executive Vice President Chief Compliance Officer | Profile | |
Paul Navarre | Executive Vice President and President International Brands | Profile | |
Maria Hilado | CFO and Executive VP | Profile | |
Ronald Taylor | Independent Director | Profile | |
Adriane Brown | Independent Director | Profile | |
Robert Hugin | Independent Director | Profile | |
Christopher Bodine | Independent Director | Profile | |
Michael Gallagher | Lead Independent Director | Profile | |
Thomas Freyman | Independent Director | Profile | |
Catherine Klema | Lead Independent Director | Profile | |
Christopher Coughlin | Lead Independent Director | Profile | |
Nesli Basgoz | Independent Director | Profile | |
Joseph Boccuzi | Independent Director | Profile | |
Patrick OSullivan | Independent Director | Profile | |
Fred Weiss | Independent Director | Profile | |
Carol Davidson | Independent Director | Profile | |
Michael Greenberg | Independent Director | Profile | |
Ron Taylor | Independent Director | Profile | |
James Bloem | Independent Director | Profile | |
Peter McDonnell | Independent Director | Profile | |
Robert Bailey | Chief Legal Officer and Corporate Secretary | Profile | |
Nicholson | Chief R&D Officer | Profile | |
James DArecca | Chief Accounting Officer | Profile | |
Alex Kelly | Chief Communications Officer | Profile | |
Karina Calzadilla | IR Contact Officer | Profile |
Allergan Plc Workforce Analysis
Traditionally, organizations such as Allergan Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Allergan Plc within its industry.Allergan Plc Manpower Efficiency
Return on Allergan Plc Manpower
Revenue Per Employee | 909.2K | |
Revenue Per Executive | 452M | |
Net Loss Per Employee | 531.6K | |
Net Loss Per Executive | 264.3M | |
Working Capital Per Employee | 16.5K | |
Working Capital Per Executive | 8.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Allergan Plc information on this page should be used as a complementary analysis to other Allergan Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |